Conceptio
›
Archive
›
ClinicalTrials.gov
ClinicalTrials.gov
public full text
Once Daily Versus Twice Daily Budesonide Orodispersible Tablets for Induction of Remission in EoE
Dr. Falk Pharma GmbH
· 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
eosinophilic esophagitis, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
#1128338
A STUDY TO ESTIMATE THE EFFECT OF PF-06651600 ON THE PHARMACOKINETICS (PK) OF ORAL CONTRACEPTIVE (OC)
#1128333
Trial Evaluating the Diagnostic Usefulness of Lumentin® 44 When Used as Contrast Agent
#1128334
Physical Exercise Augmented CBT for GAD
#1128335
Simultaneous Boost in Neoadjuvant Radiotherapy for Rectal Cancer
#1128337
Record
· ID 804548
Retrieved via
Conceptio
— every document is proof-bundled with source, license, and retrieval metadata.